The laboratory will help ensure cross-border discoveries in the field of personalized medicine and
Postgraduate University of the Okinawa InstituteScience and Technology (OIST) and Corundum Systems Biology Inc. headquartered in Tokyo launched a research project aimed at developing a fully automated system for disease prediction and drug discovery.
For three years during the first stage, the groupwill develop a highly automated analytical system and conduct complex studies of the genome, will also study factors related to metabolism, as well as symbiotic microbes, and much more.
As a result, the authors want to create a system thatwill be able to carry out autonomous scientific discoveries using artificial intelligence and robotics. The first step is the development of a fully automated complex analysis system based on intestinal and other bacteria. The project will allow for large-scale studies of human multiomics. Multiomics is an approach to biological analysis in which data sets are multiple "ohms" such as genome, proteome, transcriptome, epigenome, metabolome, and microbiome.
It is planned that the laboratory will be introduced intooperation by 2024. Starting this year, it will begin to generate biodata of standardized quality and make such studies available to different countries and regions.